December 03, 2020
Lawyers for Blue Cross Blue Shield Association and Jazz Pharmaceuticals argued that lawsuits accusing Jazz of paying off rival drugmakers to delay their generic versions of Xyrem, its blockbuster narcolepsy drug, should be consolidated on either the West Coast or the East Coast in a Thursday hearing before the Judicial Panel on Multidistrict Litigation.